510(k) · Cardiovascular

Tyto Stethoscope (G3)

by Tyto Care , Ltd.

Tyto Stethoscope (G3) is an AI-enabled medical device from Tyto Care , Ltd. that the U.S. FDA cleared through 510(k) K252089 on March 12, 2026. Its lead review panel is Cardiovascular and its primary product code is DQD (Stethoscope, Electronic).

See also FDA-cleared AI cardiovascular devices in 2026, all FDA AI clearances in 2026, top cardiovascular AI devices.

Key facts

Submission numberK252089
Pathway510(k)
Date of final decision
Company (FDA list)Tyto Care , Ltd.
Lead review panelCardiovascular
Primary product codeDQD — Stethoscope, Electronic
Applicant (openFDA)Tyto Care , Ltd.
Applicant locationNetanya, IL
Device classClass 2
Regulation number21 CFR 870.1875
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Tyto Stethoscope (G3) went through this pathway (K252089).

openFDA lists it as a Class 2 device under 21 CFR 870.1875. Class II devices are moderate risk and are subject to general and special controls.

Product code DQD covers 14 devices on the FDA AI list. By decision date, this device is #14 of 14 under that code. Tyto Care , Ltd. has 7 AI-enabled devices on the list, and the Cardiovascular panel accounts for 154 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code DQD)

More from Tyto Care , Ltd.